Health Care Select Sector SPDR Fund Rating $134.79 +0.86 (+0.64%) As of 04:10 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartDividendHeadlinesHoldingsOwnershipRatingsShort InterestBuy This Stock Health Care Select Sector SPDR Fund Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.XLV Aggregate RatingModerate Buy 2.69Holdings in XLV have an aggregate rating of Moderate Buy based on 905 analyst ratings issued in the past year covering 50 companies (97.9% of the portfolio).XLV Aggregate Price Target$134.79High Prediction$134.79Average Prediction$134.79Low Prediction$134.79Holdings in XLV have an aggregate price target of $134.79 and a range of $134.79 to $134.79 covering 50 companies (97.9% of the portfolio).XLV Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy3 Buy rating(s)Moderate Buy35 Moderate Buy rating(s)Hold12 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Health Care Select Sector SPDR Fund Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 50 XLV Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings12.47%LLYEli Lilly and Company$779.35+0.5%4.983 of 5 stars2.75$1,011.61 29.8%20Positive NewsDividend AnnouncementAnalyst Downgrade7.48%JNJJohnson & Johnson$152.58+0.1%4.9541 of 5 stars2.55$170.88 12.0%20Positive News6.79%ABBVAbbVie$185.80+1.9%4.9519 of 5 stars2.81$211.29 13.7%27Trending News5.77%UNHUnitedHealth Group$311.89+0.9%4.997 of 5 stars2.60$415.57 33.2%25Positive News4.79%ABTAbbott Laboratories$136.09+1.3%4.8868 of 5 stars2.76$142.61 4.8%21Trending News4.15%MRKMerck & Co., Inc.$79.19+0.1%4.9963 of 5 stars2.43$109.19 37.9%21Positive News3.77%ISRGIntuitive Surgical$543.41+1.8%4.2878 of 5 stars2.70$588.95 8.4%20Positive News3.22%AMGNAmgen$279.21+0.8%4.6876 of 5 stars2.35$307.82 10.2%23Trending NewsAnalyst Forecast3.16%TMOThermo Fisher Scientific$405.83-0.6%4.9926 of 5 stars2.80$604.05 48.8%20Positive News3.10%BSXBoston Scientific$107.45+0.9%4.1445 of 5 stars3.13$116.09 8.0%24Trending News2.82%PFEPfizer$24.27+0.3%4.8645 of 5 stars2.53$29.17 20.2%15Positive NewsDividend Announcement2.81%GILDGilead Sciences$110.87+0.2%4.8171 of 5 stars2.78$110.55 -0.3%27Positive News2.68%SYKStryker$395.71+0.5%4.5973 of 5 stars2.79$427.30 8.0%19Positive NewsAnalyst Downgrade2.61%DHRDanaher$197.40-0.7%4.9445 of 5 stars2.80$248.61 25.9%20Positive NewsAnalyst Upgrade2.35%VRTXVertex Pharmaceuticals$445.20+0.9%4.684 of 5 stars2.54$511.62 14.9%28Positive NewsAnalyst Revision2.30%MDTMedtronic$87.25+1.4%4.8838 of 5 stars2.63$97.87 12.2%19Positive NewsEx-DividendAnalyst Upgrade1.97%BMYBristol Myers Squibb$46.354.9867 of 5 stars2.32$58.00 25.1%22Positive News1.87%MCKMcKesson$732.50+0.9%4.6869 of 5 stars2.86$696.42 -4.9%14Positive NewsAnalyst Upgrade1.80%ELVElevance Health$389.42+2.1%4.892 of 5 stars2.75$498.87 28.1%161.79%CICigna Group$330.12+1.2%4.9489 of 5 stars3.00$380.39 15.2%20High Trading Volume1.74%CVSCVS Health$68.91+0.6%4.8993 of 5 stars2.95$75.38 9.4%20Analyst Forecast1.46%ZTSZoetis$155.86-0.2%4.8062 of 5 stars3.00$212.13 36.1%10Positive News1.40%HCAHCA Healthcare$383.21+1.0%4.746 of 5 stars2.74$395.71 3.3%19Analyst Downgrade1.11%REGNRegeneron Pharmaceuticals$525.00+0.8%4.9274 of 5 stars2.80$813.57 55.0%25Analyst Downgrade1.05%CORCencora$299.48+0.0%4.6407 of 5 stars2.82$306.33 2.3%11Positive NewsAnalyst Forecast1.00%BDXBecton, Dickinson and Company$172.31+0.8%4.9216 of 5 stars2.36$219.22 27.2%110.90%EWEdwards Lifesciences$78.34+0.2%4.3127 of 5 stars2.40$80.20 2.4%25Positive News0.89%IDXXIDEXX Laboratories$536.34+0.9%3.6756 of 5 stars2.78$546.00 1.8%9Positive News0.82%CAHCardinal Health$167.92+0.4%4.7897 of 5 stars2.79$157.43 -6.2%14Positive News0.77%RMDResMed$258.24+1.2%4.546 of 5 stars2.64$259.33 0.4%14News CoveragePositive News0.68%AAgilent Technologies$118.06-0.9%4.5938 of 5 stars2.54$140.92 19.4%13Positive NewsAnalyst Upgrade0.68%GEHCGE HealthCare Technologies$74.07-0.4%4.1616 of 5 stars2.83$88.27 19.2%12Positive News0.65%DXCMDexCom$87.29+1.1%4.8816 of 5 stars2.95$98.50 12.8%22Positive NewsAnalyst DowngradeInsider Trade0.60%HUMHumana$244.30+1.0%4.6149 of 5 stars2.30$280.76 14.9%23Ex-DividendAnalyst Upgrade0.56%CNCCentene$54.22+0.4%4.9474 of 5 stars2.56$77.71 43.3%16Positive News0.54%IQVIQVIA$157.69+0.1%4.8704 of 5 stars2.75$226.32 43.5%240.50%MTDMettler-Toledo International$1,175.56-0.8%4.6071 of 5 stars2.42$1,300.36 10.6%12Positive News0.48%STESTERIS$240.03+0.5%4.7245 of 5 stars2.63$263.83 9.9%8Positive News0.45%LHLabcorp$262.39+0.7%4.4399 of 5 stars2.79$276.08 5.2%14Positive News0.44%PODDInsulet$314.18+0.4%4.1797 of 5 stars2.83$321.00 2.2%18Positive News0.42%WATWaters$349.93-0.7%4.5167 of 5 stars2.61$388.00 10.9%18Trending News0.41%DGXQuest Diagnostics$179.52+1.0%4.9423 of 5 stars2.69$185.73 3.5%16Positive News0.39%BIIBBiogen$125.59-0.4%4.9504 of 5 stars2.38$188.48 50.1%320.38%ZBHZimmer Biomet$91.23-0.3%4.8491 of 5 stars2.29$111.53 22.2%21Analyst Revision0.34%MOHMolina Healthcare$297.09+0.0%4.8247 of 5 stars2.44$364.21 22.6%16Positive NewsAnalyst Downgrade0.32%WSTWest Pharmaceutical Services$218.800.0%4.726 of 5 stars2.89$320.00 46.3%90.32%BAXBaxter International$30.33-0.2%4.1284 of 5 stars2.44$37.25 22.8%90.30%HOLXHologic$65.16+0.2%4.707 of 5 stars2.41$77.42 18.8%17Positive News0.29%COOCooper Companies$71.16+0.0%4.0101 of 5 stars2.73$99.70 40.1%11Trending NewsAnalyst Upgrade0.26%ALGNAlign Technology$189.33+0.4%4.8393 of 5 stars2.67$241.25 27.4%15News CoveragePositive News This page (NYSEARCA:XLV) was last updated on 6/30/2025 by MarketBeat.com Staff From Our PartnersWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | Sponsored379 passengers walked away from thisElon Musk just wrote a $51 million check to back this material’s next phase… Because it’s not just saving l...True Market Insiders | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredConsumer apocalypse imminent (7 ominous red flags)The #1 Gold play right now (not a miner, ETF, or bullion) Gold is up 237% since 2008... but one gold invest...Stansberry Research | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Health Care Select Sector SPDR Fund Please log in to your account or sign up in order to add this asset to your watchlist. Share Health Care Select Sector SPDR Fund With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
